|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004482,
umls-concept:C0010592,
umls-concept:C0019196,
umls-concept:C0023911,
umls-concept:C0034897,
umls-concept:C0038317,
umls-concept:C0205462,
umls-concept:C0220847,
umls-concept:C0332287,
umls-concept:C0376387,
umls-concept:C0676831,
umls-concept:C1442162,
umls-concept:C1521828,
umls-concept:C1550718,
umls-concept:C1696465,
umls-concept:C1707455
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2004-12-15
|
|
pubmed:abstractText |
Hepatitis C virus (HCV) recurrence in HCV+ liver transplant recipients is almost inevitable and may be promoted by immunosuppression. We compared the amount of liver damage with regard to usage of steroids and basiliximab.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:AgnesSalvatoreS,
pubmed-author:BurraPatriziaP,
pubmed-author:CalleaFrancescoF,
pubmed-author:De CarlisLucianoL,
pubmed-author:FassatiLuigi RaineroLR,
pubmed-author:FerraraRobertoR,
pubmed-author:FilipponiFrancoF,
pubmed-author:GraziGian LucaGL,
pubmed-author:PisatiRobertoR,
pubmed-author:RisalitiAndreaA,
pubmed-author:RossiMassimoM,
pubmed-author:SalizzoniMauroM,
pubmed-author:ValenteUmbertoU
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1488-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15599313-Adrenal Cortex Hormones,
pubmed-meshheading:15599313-Adult,
pubmed-meshheading:15599313-Aged,
pubmed-meshheading:15599313-Antibodies, Monoclonal,
pubmed-meshheading:15599313-Azathioprine,
pubmed-meshheading:15599313-Cyclosporine,
pubmed-meshheading:15599313-Double-Blind Method,
pubmed-meshheading:15599313-Drug Therapy, Combination,
pubmed-meshheading:15599313-Female,
pubmed-meshheading:15599313-Graft Survival,
pubmed-meshheading:15599313-Hepacivirus,
pubmed-meshheading:15599313-Hepatitis C,
pubmed-meshheading:15599313-Humans,
pubmed-meshheading:15599313-Immunosuppressive Agents,
pubmed-meshheading:15599313-Liver Transplantation,
pubmed-meshheading:15599313-Male,
pubmed-meshheading:15599313-Middle Aged,
pubmed-meshheading:15599313-Placebos,
pubmed-meshheading:15599313-Recombinant Fusion Proteins,
pubmed-meshheading:15599313-Recurrence,
pubmed-meshheading:15599313-Time Factors,
pubmed-meshheading:15599313-Virus Replication
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.
|
|
pubmed:affiliation |
Liver Transplantation Unit, University of Pisa, Hospital of Cisanello, Via Paradisa 2, 56100 Pisa, Italy. f.filipponi@med.unipi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
